Skip to main content
. 2018 Oct 8;2018:1020925. doi: 10.1155/2018/1020925

Table 2.

Clinical characteristics of 4 subgroups of patients with chronic HBV infection.

IT IC LR RA p-value
Subjects, n 19 20 18 20 /
Gender, males/females 10/9 12/8 11/7 12/8 0.950
Age, y 29(18-52) 29(18-56) 41.5(18-71) 42(24-65) 0.002
ALT, IU/L 27(16-38) 293(85-939) 25.5(15-34) 332(57-942) <0.001
AST, IU/L 28(13-38) 129(51-491) 22(19-34) 177.5(39-915) <0.001
HBV DNA, log10 IU/mL 7.87(6.45-8.38) 7.76(3.72-8.23) 2.36(0-3.20) 5.51(2.00-8.23) <0.001
HBsAg, log10 IU/mL 4.557(3.495-4.54) 3.85(2.85-4.60) 2.69(1.35-3.53) 3.32(1.30-4.61) <0.001
HBeAg, positive/negative, n 19/0 20/0 0/18 0/20 <0.001
ALT, elevated/normal, n 0/19 20/0 0/18 20/0 <0.001

(a) Values are expressed as median (minimum-maximum) for age, ALT, AST, and HBV DNA.

(b) HBV DNA<100 was treated as 0 log10 IU/ml.

(c) HBsAg<20 was treated as 20.